Table 2.
The distribution of the gastric mucosal pathology related to expression of CD44 and polymorphisms.
| Polymorphism of gastric mucosal pathology | Expression of CD44 protein (%) | OR (95% CI) | p value | |
|---|---|---|---|---|
| Negative | Positive | |||
| Precancerous (n = 113)a | ||||
| (i) AA | 10.71 | 7.14 | 0.68 (0.47–0.96) | 0.693 |
| (ii) AG | 35.71 | 14.28 | 0.91 (0.87–1.86) | 0.058 |
| (iii) GG | 28.57 | - | - | - |
| Gastric cancer (n = 162)a | ||||
| (i) AA | - | 2.56 | - | - |
| (ii) AG | 7.69 | 35.89 | 5.67 (1.54–7.23) | 0.024∗ |
| (iii) GG | 10.25 | 43.58 | 8.32 (2.94–11.42) | 0.016∗ |
| Gastric cancer (n = 162)b | ||||
| (i) AG | 7.69 | 35.89 | 3.28 (2.47–5.63) | 0.036∗ |
| (ii) GG | 10.25 | 43.58 | 4.14 (1.84–7.32) | 0.046∗ |
aUnivariate Cox regression model analysis used to analyze the data. bMultivariate Cox proportional hazards regression model analysis was used to analyze the data. OR, odds ratio; CI, confidence interval. ∗Significance is set at p < 0.05.